Publications by authors named "Nora Fagan"

Claim this Profile
T
Two-year treatment experience with BI 655064, an antagonistic anti-CD40 antibody, in patients with active lupus nephritis: An exploratory, phase II maintenance trial.
Richard Furie, Jürgen Steffgen, Nora Fagan, Juanita Romero-Diaz, Yingyos Avihingsanon

Lupus· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II study of avenciguat, a novel soluble guanylate cyclase activator, in patients with systemic sclerosis: Study design and rationale of the VITALISScE™ study.
Dinesh Khanna, Jeska de Vries-Bouwstra, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Andrea Hsiu Ling Low, Nora Fagan

J Scleroderma Relat Disord· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Biomarker Responses to BI 655064, an Antagonistic Anti-CD40 Antibody, in Patients With Active Lupus Nephritis: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.
David R Jayne, Jürgen Steffgen, Juanita Romero-Diaz, Ingeborg Bajema, Dimitrios T Boumpas, Nora Fagan

Arthritis Rheumatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 dose escalation trial of volasertib in combination with decitabine in patients with acute myeloid leukemia.
Jorge Cortes, Nikolai Podoltsev, Hagop Kantarjian, Gautam Borthakur, Amer M Zeidan, Nora Fagan

Int J Hematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function.
Erik J M van Bommel, Yuliya Lytvyn, Bruce A Perkins, Nima Soleymanlou, Nora M Fagan

Kidney Int· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson's Disease.
William Seiple, Danna Jennings, Richard B Rosen, Leona Borchert, Lee Canale, Nora Fagan

Parkinsons Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.
Bruce A Perkins, David Z I Cherney, Nima Soleymanlou, Justin A Lee, Helen Partridge, Nora Fagan

PLoS One· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial.
Bruce A Perkins, David Z I Cherney, Helen Partridge, Nima Soleymanlou, Holly Tschirhart, Nora M Fagan

Diabetes Care· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus.
David Z I Cherney, Bruce A Perkins, Nima Soleymanlou, Maria Maione, Vesta Lai, Nora M Fagan

Circulation· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus.
David Zi Cherney, Bruce A Perkins, Nima Soleymanlou, Ronnie Har, Nora Fagan

Cardiovasc Diabetol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease.
Shari A Brazinsky, Robert J Lapidus, Laurence A Weiss, Mo Ghafouri, Nora M Fagan

Clin Drug Investig· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis